The Bipolar Association Case-Control Study (BACCS) and meta-analysis: No association with the 5,10-methylenetetrahydrofolate reductase gene and bipolar disorder

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 153, Issue 7, 2010, Pages 1298-1304

  Cohen Woods, Sarah ^a   Craig, Ian ^a   Gaysina, Darya ^a   Gray, Joanna ^a   Gunasinghe, Cerisse ^a   Craddock, Nick ^b   Elkin, Amanda ^a   Jones, Lisa ^c   Kennedy, James ^d   King, Nicole ^d   Korszun, Ania ^e   Knight, Jo ^a   Owen, Michael ^b   Parikh, Sagar ^d   Strauss, John ^d   Sterne, Abram ^a   Tozzi, Federica ^f   Perry, Julia ^f   Muglia, Pierandrea ^f   Vincent, John ^d   McGuffin, Peter ^a   Farmer, Anne ^a   more..

^a KING'S COLLEGE LONDON   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^f GLAXOSMITHKLINE   (United States)

Author keywords

Bipolar disorder; Genetics; Manic depression; Mood disorder; MTHFR

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ADULT; ARTICLE; BIPOLAR DISORDER; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ALLELES; BIPOLAR DISORDER; CASE-CONTROL STUDIES; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 77957336338     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.31101     Document Type: Article

References (50)

1. American Psychiatric Association. 1994. Diagnostic and Statistical Manual, 4th edition. Washington, DC: American Psychiatric Press.
2. Andreoli VM, Maffei F. 1975. Letter: Blood-levels of S-adenosylmethionine in schizophrenia. Lancet 2:922.
3. Anguelova M, Benkelfat C, Turecki G. 2003. A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: I. Affective disorders. Mol Psychiatry 8:574-591. (Pubitemid 36898017)
4. Arinami T, Yamada N, Yamakawa-Kobayashi K, Hamaguchi H, Toru M. 1997. Methylenetetrahydrofolate reductase variant and schizophrenia/depression. Am J Med Genet 74:526-528.
5. Beck AT, Steer RA. 1984. Internal consistencies of the original and revised Beck Depression Inventory. J Clin Psychol 40:1365-1367.
6. Begg CB, Mazumdar M. 1994. Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-1101.
7. Bottiglieri T, Hyland K, Reynolds EH. 1994. The clinical potential of ademetionine (S-adenosylmethionine) in neurological disorders. Drugs 48:137-152.
8. Botto LD, Yang Q. 2000. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: A HuGE review. Am J Epidemiol 151:862-877.
9. Chen CS, Tsai JC, Tsang HY, Kuo YT, Lin HF, Chiang IC, Devanand DP. 2005. Homocysteine levels, MTHFR C677T genotype, and MRI Hyperintensities in late-onset major depressive disorder. Am J Geriatr Psychiatry 13:869-875.
10. Chen Z, Liu Y, Zhang D, Liu Z, Wang P, Zhou D, Zhao T, Wang T, Xu H, Li S, Feng G, He L, Yu L. 2009. C677T methylenetetrahydrofolate reductase gene polymorphisms in bipolar disorder: An association study in the Chinese population and a meta-analysis of genetic association studies. Neurosci Lett 449:48-51.
11. Coppen A, Abou-Saleh MT. 1982. Plasma folate and affective morbidity during long-term lithium therapy. Br J Psychiatry 141:87-89.
12. Coppen A, Chaudhry S, Swade C. 1986. Folic acid enhances lithium prophylaxis. J Affect Disord 10:9-13.
13. Dupont WD, Plummer WD Jr. 1990. Power and sample size calculations. A review and computer program. Control Clin Trials 11:116-128.
14. Freeman JM, Finkelstein JD, Mudd SH. 1975. Folate-responsive homocystinuria and "schizophrenia". A defect in methylation due to deficient 5,10-methylenetetrahydrofolate reductase activity. N Engl J Med 292:491-496.
15. Freeman B, Powell J, Ball D, Hill L, Craig I, Plomin R. 1997. DNA by mail: An inexpensive and noninvasive method for collecting DNA samples from widely dispersed populations. Behav Genet 27:251-257.
16. Freeman B, Smith N, Curtis C, Huckett L, Mill J, Craig IW. 2003. DNA from buccal swabs recruited by mail: Evaluation of storage effects on long-term stability and suitability for multiplex polymerase chain reaction genotyping. Behav Genet 33:67-72.
17. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den HM, Kluijtmans LA, van den Heuvel LP. 1995. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113.
18. Gaysina D, Cohen S, Craddock N, Farmer A, Hoda F, Korszun A, Owen MJ, Craig IW, McGuffin P. 2008. No association with the 5,10- methylenetetrahydrofolate reductase gene and major depressive disorder: Results of the depression case control (DeCC) study and a meta-analysis. Am J Med Genet B Neuropsychiatr Genet 147B:699-706.
19. Gilbody S, Lewis S, Lightfoot T. 2007. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: A HuGE review. Am J Epidemiol 165:1-13.
20. Godfrey PS, Toone BK, Carney MW, Flynn TG, Bottiglieri T, Laundy M, Chanarin I, Reynolds EH. 1990. Enhancement of recovery from psychiatric illness by methylfolate. Lancet 336:392-395.
21. Goren JL, Stoll AL, Damico KE, Sarmiento IA, Cohen BM. 2004. Bioavailability and lack of toxicity of S-adenosyl-L-methionine (SAMe) in humans. Pharmacotherapy 24:1501-1507.
22. Hasanah CI, Khan UA, Musalmah M, Razali SM. 1997. Reduced red-cell folate in mania. J Affect Disord 46:95-99.
23. Hickie I, Scott E, Naismith S, Ward PB, Turner K, Parker G, Mitchell P, Wilhelm K. 2001. Late-onset depression: Genetic, vascular and clinical contributions. Psychol Med 31:1403-1412.
24. Higgins JP, Thompson SG, Deeks JJ, Altman DG. 2003. Measuring inconsistency in meta-analyses. BMJ 327:557-560.
25. Jonsson EG, Larsson K, Vares M, Hansen T, Wang AG, Djurovic S, Ronningen KS, Andreassen OA, Agartz I, Werge T, Terenius L, Hall H. 2008. Two methylenetetrahydrofolate reductase gene (MTHFR) polymorphisms, schizophrenia\and bipolar disorder: An association study. Am J Med Genet Part B 147B:976-982.
26. Kelly CB, McDonnell AP, Johnston TG, Mulholland C, Cooper SJ, McMaster D, Evans A, Whitehead AS. 2004. The MTHFR C677T polymorphism is associated with depressive episodes in patients from Northern Ireland. J Psychopharmacol 18:567-571.
27. Kempisty B, Mostowska A, Gorska I, Luczak M, Czerski P, Szczepankiewicz A, Hauser J, Jagodzinski PP. 2006. Association of 677C>T polymorphism of methylenetetrahydrofolate reductase (MTHFR) gene with bipolar disorder and schizophrenia. Neurosci Lett 400:267-271.
28. Kunugi H, Fukuda R, Hattori M, Kato T, Tatsumi M, Sakai T, Hirose T, Nanko S. 1998. C677T polymorphism in methylenetetrahydrofolate reductase gene and psychoses. Mol Psychiatry 3:435-437.
29. Licinio J. 2002. Gene-environment interactions in molecular psychiatry. Mol Psychiatry 7:123-124.
30. McGuffin P, Katz R, Aldrich J. 1986. Past and present state examination: The assessment of 'lifetime ever' psychopathology. Psychol Med 162:461-465.
31. Ozbek Z, Kucukali CI, Ozkok E, Orhan N, Aydin M, Kilic G, Sazci A, Kara I. 2008. Effect of the methylenetetrahydrofolate reductase gene polymorphisms on homocysteine, folate and vitamin B12 in patients with bipolar disorder and relatives. Prog Neuropsychopharmacol Biol Psychiatry 32:1331-1337.
32. Pasquier F, Lebert F, Petit H, Zittoun J, Marquet J. 1994. Methylenetetrahydrofolate reductase deficiency revealed by a neuropathy in a psychotic adult. J Neurol Neurosurg Psychiatry 57:765-766.
33. Regland B, Germgard T, Gottfries CG, Grenfeldt B, Koch-Schmidt AC. 1997. Homozygous thermolabile methylenetetrahydrofolate reductase in schizophrenia-like psychosis. J Neural Transm 104:931-941.
34. Regland B, Johansson BV, Gottfries CG. 1994. Homocysteinemia and schizophrenia as a case of methylation deficiency. J Neural Transm Gen Sect 98:143-152.
35. Regland B, Johansson BV, Grenfeldt B, Hjelmgren LT, Medhus M. 1995. Homocysteinemia is a common feature of schizophrenia. J Neural Transm Gen Sect 100:165-169.
36. Reif A, Pfuhlmann B, Lesch KP. 2005. Homocysteinemia as well as methylenetetrahydrofolate reductase polymorphism are associated with affective psychoses. Prog Neuropsychopharmacol Biol Psychiatry 29:1162-1168.
37. Rosenblatt DS. 1995. Inherited disorders of folate transport and metabolism. In: Scriver CrR, Beaudet AL, Sly wS, Velle D, editors. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill. pp 3111-3128.
38. Rozen R. 1996. Molecular genetics of methylenetetrahydrofolate reductase deficiency. J Inherit Metab Dis 19:589-594.
39. Salanti G, Sanderson S, Higgins JP. 2005. Obstacles and opportunities in meta-analysis of genetic association studies. Genet Med 7:13-20.
40. Sham PC, Sterne A, Purcell S, Cherny S, Webster M, Rijsdijk F, Asherson P, Ball D, Craig I, Eley T, Goldberg D, Gray J, Mann A, Owen M, Plomin R. 2000. GENESiS: Creating a composite index of the vulnerability to anxiety and depression in a community-based sample of siblings. Twin Res 3:316-322.
41. Smith AL, Weissman MM. 1992. Epidemiology. In: ES, Paykel editor. Handbook of Affective Disorders. Edinburgh: Churchill Livingstone. pp 111-129.
42. Tan EC, Chong SA, Lim LC, Chan AO, Teo YY, Tan CH, Mahendran R. 2004. Genetic analysis of the thermolabile methylenetetrahydrofolate reductase variant in schizophrenia and mood disorders. Psychiatr Genet 14:227-231.
43. Ueland PM, Hustad S, Schneede J, Refsum H, Vollset SE. 2001. Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci 22:195-201.
44. van Praag HM. 1982. Depression. Lancet 2:1259-1264.
45. Van Tonder SV, Metz J, Green R. 1975. Vitamin B12 metabolism in the fruit bat (Rousettus aegyptiacus). The induction of vitamin B12 deficiency and its effect on folate levels. Br J Nutr 34:397-410.
46. Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, Joyce PR, Karam EG, Lee CK, Lellouch J, Lepine JP, Newman SC, Rubio-Stipec M, Wells JE, Wickramaratne PJ, Wittchen H, Yeh EK. 1996. Cross-national epidemiology of major depression and bipolar disorder. JAMA 276:293-299.
47. Wing JK, Babor T, Brugha T, Burke J, Cooper JE, Giel R, Jablenski A, Regier D, Sartorius N. 1990. SCAN. Schedules for Clinical Assessment in Neuropsychiatry. Arch Gen Psychiatry 47:589-593.
48. World Health Organisation. 1998. Diagnosis and Clinical Measurement in Psychiatry. A Reference Manual for SCAN. Geneva: World Health Organisation.
49. World Health Organisation. 1993. The ICD-10 Classification of Mental and Behavioural Disorders Diagnostic Criteria for Research. Geneva: World Health Organisation.
50. Zintzaras E. 2006. C677T and A1298C methylenetetrahydrofolate reductase gene polymorphisms in schizophrenia, bipolar disorder and depression: A meta-analysis of genetic association studies. Psychiatr Genet 16:105-115.